頁籤選單縮合
題名 | 市售中藥濃縮製劑指標成分含量調查=Investigation on the Marker Constituents of Concentrated Chinese Medicinal Preparations |
---|---|
作者 | 林雅姿; 鄭淑晶; 秦玲; 黃坤森; 林秀珍; 盧芬鈴; 曾木全; 劉宜祝; 林哲輝; 羅吉方; | 書刊名 | 食品藥物研究年報 |
卷期 | 1 2010.11[民99.11] |
頁次 | 頁248-253 |
分類號 | 412.36 |
關鍵詞 | 中藥濃縮製劑; 六味地黃丸; 黃連解毒湯; 知柏地黃丸; 杞菊地黃丸; 高效液相層析法; 指標成分; Concentrated Chinese medicinal preparations; Liu-Wei-Di-Huang-Wan; Huang-Lian-Jie-Du-Wan; Zhi-Bo-Di-Huang-Wan; Qi-Ju-Di-Huang-Wan; HPLC; Marker constituents; |
語文 | 中文(Chinese) |
中文摘要 | 摘 要 為瞭解國人使用中藥濃縮製劑之品質,本計畫係延續第3年之品質調查計畫,98年度選 定六味地黃丸、黃連解毒湯、知柏地黃丸及杞菊地黃丸等4種中藥濃縮製劑,並於98年2月 至5月間向17家中藥廠價購該4類產品,共計購得59件市售檢體,採高效液相層析法檢測其 指標成分含量,檢驗結果,59件中有14件不符合廠商自訂之規格範圍,本計畫檢驗結果將 提供作為行政管理之參考。 |
英文摘要 | ABSTRACT In order to assess the quality of the concentrated traditional Chinese medicinal preparations, a continuous investigation plan has been implemented since 2007. In 2009, 59 samples, including Liu-Wei-Di-Huang- Wan, Huang-Lian-Jie-Du-Wan, Zhi-Bo-Di-Huang-Wan and Qi-Ju-Di-Huang-Wan, were purchased from pharmaceutical manufacturers from Feb. to Apr. 2009. Based on the registered specifications, HPLC method was applied to determine the marker constituents in these preparations. The results indicated that 14 samples were out of specifications. That will provide as a reference of the administration. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。